EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Adrenal suppression secondary to inhaled corticosteroids

Corin MacPhail, Elizabeth Rosolowsky, Connie Yang, Teresa Pinto, Carly Baxter, Anne Hicks iD

Paediatrics & Child Health · 15.06.2026

DOI: 10.1093/pch/pxag048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Paediatrics & Child Health, online erschienen am 15.06.2026. Verfasst von Corin MacPhail und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Women, Health Research Institute, Department of Pediatrics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhaled corticosteroids (ICS) are the foundation of treatment for pediatric asthma, and ICS are significantly safer than repeated courses of systemic steroids. However, systemic effects from ICS include adrenal suppression (AS), which is under recognized and can be life-threatening. Signs and symptoms of AS are often subtle and can be difficult to recognize. The Canadian Pediatric Society and Adrenal Suppression Working Group recommend screening for AS in: asymptomatic children receiving high dose ICS therapy for ≥3 months, any dose ICS in conjunction with a CYP3A4 inhibitor, and any children with AS symptoms, regardless of ICS dose. Screening should be done with a morning serum cortisol, and consultation with Pediatric Endocrinology is warranted if morning cortisol is low or there is high clinical suspicion. Factors such as age-specific dosing, ICS administration technique and adherence, comorbidities, and triggers should be considered when managing asthma to decrease risk of AS.

Schlagwörter

Stichwörter der Autor:innen

Adrenal insufficiencyAdrenal suppressionAsthmaInhaled corticosteroid

Autor:innen und Institutionen

  • Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • Division of Pediatric Respirology, Department of Pediatrics, Faculty of Medicine & Dentistry, University of Toronto, Toronto, Ontario, Canada.
  • Division of Pediatric Endocrinology, Department of Pediatrics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Division of Pediatric Respirology, Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.

ORCID-Profile: Anne Hicks

Förderung

  • Women
  • Health Research Institute
  • Department of Pediatrics

Zitieren

APA

MacPhail, C., Rosolowsky, E., Yang, C., Pinto, T., Baxter, C., & Hicks, A. (2026). Adrenal suppression secondary to inhaled corticosteroids. Paediatrics & Child Health. https://doi.org/10.1093/pch/pxag048

Vancouver

MacPhail C, Rosolowsky E, Yang C, Pinto T, Baxter C, Hicks A. Adrenal suppression secondary to inhaled corticosteroids. Paediatrics & Child Health. 2026. doi:10.1093/pch/pxag048

BibTeX
@article{MacPhail2026,
  author = {MacPhail, Corin and Rosolowsky, Elizabeth and Yang, Connie and Pinto, Teresa and Baxter, Carly and Hicks, Anne},
  title = {Adrenal suppression secondary to inhaled corticosteroids},
  journal = {Paediatrics & Child Health},
  year = {2026},
  doi = {10.1093/pch/pxag048}
}
Kostenlos starten →